Wedbush Securities’s T2 Biosystems, Inc TTOO Stock Holding History

Wedbush Securities’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2	Closed	-$12K	–	1028
2019 Q4	$12K	Buy	+2	New	+$18.9K	﹤0.01%	987

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wedbush Securities's TTOO Position: Q1 2020 in Review

Wedbush Securities sold out of T2 Biosystems, Inc (TTOO) in Q1 2020, closing a stake of 2 shares — an estimated $12K sold.

Wedbush Securities first reported a position in TTOO in Q4 2019 and held it in 1 quarter. The position peaked at $12K in Q4 2019. 39 funds tracked by Wall St. Rank hold TTOO as of Q1 2020.

Wedbush Securities reported no remaining T2 Biosystems, Inc position as of Q1 2020 after selling out during the quarter.
Wedbush Securities sold 2 T2 Biosystems, Inc shares in Q1 2020, an estimated $12K.
Wedbush Securities first reported a position in T2 Biosystems, Inc in Q4 2019 and held it in 1 quarter.
Wedbush Securities's T2 Biosystems, Inc position peaked at $12K in Q4 2019.
39 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2020.

Based on Wedbush Securities's 13F filing for Q1 2020, filed 17 Apr 2020.